Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent genomic studies. Among genetic lesions that are recurrent in CLL, few clinically validated prognostic markers, such as TP53 mutations and 17p deletion, […]
Breakthrough may lead to new treatments for chronic infection. Scientists at Nanyang Technological University, Singapore (NTU Singapore) have discovered that antibiotics can continue to be effective if bacteria’s cell-to-cell communication and ability to latch on […]
Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test. The […]
Scientists at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials of therapies for leukaemia and lymphoma. In a study published in Nature Communications, they […]
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard Medical School, today announced that the Journal of Clinical Oncology has published a paper showing the […]
Celiac disease is a relatively common immune disorder, affecting an estimated 1 in 250 Americans. The exact causes of the disease are still shrouded in mystery; new research, published in Science, uncovers a potential link […]
Copyright © 2021 | MH Magazine WordPress Theme by MH Themes